Lacosamide controlled release (Adamas Pharmaceuticals)

N/A

Report date: 2022/09/04 11:40:35

Base Information

Drug NameLacosamide controlled release (Adamas Pharmaceuticals)
Drug Alias NameLacosamide extended release capsuleADS-4101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdamas Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamas Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsEpilepsy

Other Information

ATC CodeN/A
Related LinksN/A